TAVIST ALLERGY/SINUS/HEADACHE Drug Patent Profile
✉ Email this page to a colleague
When do Tavist Allergy/sinus/headache patents expire, and what generic alternatives are available?
Tavist Allergy/sinus/headache is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in TAVIST ALLERGY/SINUS/HEADACHE is acetaminophen; clemastine fumarate; pseudoephedrine hydrochloride. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; clemastine fumarate; pseudoephedrine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TAVIST ALLERGY/SINUS/HEADACHE?
- What are the global sales for TAVIST ALLERGY/SINUS/HEADACHE?
- What is Average Wholesale Price for TAVIST ALLERGY/SINUS/HEADACHE?
Summary for TAVIST ALLERGY/SINUS/HEADACHE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 179 |
| Patent Applications: | 4,219 |
| DailyMed Link: | TAVIST ALLERGY/SINUS/HEADACHE at DailyMed |
US Patents and Regulatory Information for TAVIST ALLERGY/SINUS/HEADACHE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | TAVIST ALLERGY/SINUS/HEADACHE | acetaminophen; clemastine fumarate; pseudoephedrine hydrochloride | TABLET;ORAL | 021082-001 | Mar 1, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
